Vaxil BioTherapeutics Israeli Company
Vaxil BioTherapeutics is a clinical-stage company developing immunotherapeutic products, including long peptide vaccines and antibodies to treat cancer and infectious diseases. Vaxils products are derived from its fully owned proprietary technology, VaxHit, which uses the signal peptide domains in selected targets as core antigens.
Health Tech & Life Sciences
Biotechnology
Health Diagnostics
Therapeutics
Alternatives
No alternatives listed yet.
Suggest an Alternative
Founders
Office Locations
Toronto, Canada
References
[1]
finder.startupnationcentral.org
- https://finder.startupnationcentral.org/company_page/vaxil-biotherapeutics
[2]
crunchbase.com
- https://www.crunchbase.com/organization/vaxil-biotherapeutics
External links are provided for reference and verification purposes.